Lu Y - Search Results

1

Folate receptor-targeted immunotherapy of cancer: mechanism and therapeutic potential.

Lu Y, Sega E, Leamon CP, Low PS. Lu Y, et al. Adv Drug Deliv Rev. 2004 Apr 29;56(8):1161-76. doi: 10.1016/j.addr.2004.01.009. Adv Drug Deliv Rev. 2004. PMID: 15094213 Review.

2

Folate targeting of haptens to cancer cell surfaces mediates immunotherapy of syngeneic murine tumors.

Lu Y, Low PS. Lu Y, et al. Cancer Immunol Immunother. 2002 May;51(3):153-62. doi: 10.1007/s00262-002-0266-6. Epub 2002 Mar 19. Cancer Immunol Immunother. 2002. PMID: 11941454 Free PMC article.

3

Folate-mediated delivery of macromolecular anticancer therapeutic agents.

Lu Y, Low PS. Lu Y, et al. Adv Drug Deliv Rev. 2002 Sep 13;54(5):675-93. doi: 10.1016/s0169-409x(02)00042-x. Adv Drug Deliv Rev. 2002. PMID: 12204598 Review.

4

Targeted immunotherapy of cancer: development of antibody-induced cellular immunity.

Lu Y, Low PS. Lu Y, et al. J Pharm Pharmacol. 2003 Feb;55(2):163-7. doi: 10.1211/002235702540. J Pharm Pharmacol. 2003. PMID: 12635651 Review.

5

Immunotherapy of folate receptor-expressing tumors: review of recent advances and future prospects.

Lu Y, Low PS. Lu Y, et al. J Control Release. 2003 Aug 28;91(1-2):17-29. doi: 10.1016/s0168-3659(03)00215-3. J Control Release. 2003. PMID: 12932634 Review.

6

Folate receptor-targeted immunotherapy: induction of humoral and cellular immunity against hapten-decorated cancer cells.

Lu Y, Sega E, Low PS. Lu Y, et al. Int J Cancer. 2005 Sep 20;116(5):710-9. doi: 10.1002/ijc.21126. Int J Cancer. 2005. PMID: 15828051

7

Preclinical pharmacokinetics, tissue distribution, and antitumor activity of a folate-hapten conjugate-targeted immunotherapy in hapten-immunized mice.

Lu Y, Xu LC, Parker N, Westrick E, Reddy JA, Vetzel M, Low PS, Leamon CP. Lu Y, et al. Mol Cancer Ther. 2006 Dec;5(12):3258-67. doi: 10.1158/1535-7163.MCT-06-0439. Mol Cancer Ther. 2006. PMID: 17172429

8

Folate-targeted dinitrophenyl hapten immunotherapy: effect of linker chemistry on antitumor activity and allergic potential.

Lu Y, You F, Vlahov I, Westrick E, Fan M, Low PS, Leamon CP. Lu Y, et al. Mol Pharm. 2007 Sep-Oct;4(5):695-706. doi: 10.1021/mp070050b. Epub 2007 Sep 5. Mol Pharm. 2007. PMID: 17784727

9

Low-dose radiation potentiates the therapeutic efficacy of folate receptor-targeted hapten therapy.

Sega EI, Lu Y, Ringor M, Leamon CP, Low PS. Sega EI, et al. Among authors: lu y. Int J Radiat Oncol Biol Phys. 2008 Jun 1;71(2):559-66. doi: 10.1016/j.ijrobp.2008.02.010. Epub 2008 Apr 12. Int J Radiat Oncol Biol Phys. 2008. PMID: 18411004

10

Strategy to prevent drug-related hypersensitivity in folate-targeted hapten immunotherapy of cancer.

Lu Y, Klein PJ, Westrick E, Xu LC, Santhapuram HK, Bloomfield A, Howard SJ, Vlahov IR, Ellis PR, Low PS, Leamon CP. Lu Y, et al. AAPS J. 2009 Sep;11(3):628-38. doi: 10.1208/s12248-009-9139-7. AAPS J. 2009. PMID: 19728104 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

47,805 results

Search Page

Filters